5/10 RegenMD

RegenMD         Heart Tissue Repairs Itself Through New Controllable Platform May 9, 2011 at 2:52 PM   Columbia Engineering researchers have developed a tissue-engineering platform that is capable of "patching" a damaged heart. Gordana Vunjak-Novakovic, study leader and professor of Biomedical Engineering at Columbia University's Fu Foundation School of ... See all stories on this topic » DailyTech         UCSF stem cell studies to focus on muscular dystrophy, heart disease, cancer May 9, 2011 at 11:55 AM   Three UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their investigations of treatment strategies for degenerative muscle diseases, such as muscular dystrophy, and heart disease, and to determine ... See all stories on this topic »         Columbia Engineers Patch A Heart May 9, 2011 at 10:49 AM   We have established a tissue engineering platform for the delivery of human mesenchymal progenitor cells (MPCs) by a fully biological composite scaffold. Specifically, we developed a method for complete decellularization of human myocardium that leaves ... See all stories on this topic »         Clemson University's Karen Burg elected president of scientific society May 9, 2011 at 10:49 AM   With a focus on reconstruction of breast tissue following cancer surgery, Burg's research into tissue engineering, biofabrication and absorbable polymers has led to 11 issued or pending US patents. Her work is funded by the National Science Foundation ... See all stories on this topic »         Aesthetic Plastic Surgery and Anti Aging Medicine symposium to focus on the ... May 9, 2011 at 5:17 AM   The 2nd Aesthetic Plastic Surgery and Anti Aging Medicine: The Next Generation Symposium is a 3 day interactive symposium featuring advances in regenerative medicine and minimally invasive surgery. The Symposium will be held at the Waldorf Astoria in ... See all stories on this topic »         California Institute for Regenerative Medicine awards $25 mn for Geron's ... May 9, 2011 at 5:17 AM   Geron Corporation announced that the company has been approved to receive a Targeted Clinical Development Award totalling $25 million from the California Institute for Regenerative Medicine (CIRM). The funding will support the clinical development of ... See all stories on this topic »             This email was sent to regenmd@gmail.com. Delivered by Feed My Inbox PO Box 682532 Franklin, TN 37068 Account Login Unsubscribe Here